The Massachusetts Life Sciences Center (MLSC) team joined leadership from Thermo Fisher Scientific, along with industry partners and state and local officials, to cut the ribbon on a new Bioprocess Design Center (BDC) at the company’s facility in Plainville, Massachusetts. MLSC Chief Business Officer Jeanne LeClair and Massachusetts Economic Development Secretary Eric Paley participated in the ceremony, highlighting a continued investment in the Commonwealth’s advanced biomanufacturing ecosystem.
The new 4,000-square-foot Bioprocess Design Center will enable biotech and pharmaceutical companies to accelerate development processes, supporting the faster delivery of life-saving therapies to patients worldwide.
Located within Thermo Fisher’s approximately 300,000-square-foot Plainville campus, the BDC enhances the site’s existing capabilities in viral vector development and aseptic sterile fill-finish manufacturing. The facility supports the production of biologics and advanced therapies targeting diseases including cancer, Parkinson’s disease, hemophilia B, and Duchenne muscular dystrophy.
The MLSC has a long partnership with Thermo Fisher which includes the employment of 22 graduates through the MLSC’s Pathmaker program along with the purchase of equipment and supplies on behalf of MLSC Education and Workforce Development Grant recipients. The opening of the Bioprocess Design Center further expands the company’s footprint in the Commonwealth and reinforces Massachusetts’ position as a global leader in biomanufacturing and the life sciences.
